Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Naba Al-Hayat Pharmaceutical Industry is a prominent Iraqi pharmaceutical company dedicated to the manufacturing and distribution of high-quality generic medicines. Based in Baghdad, the company operates a state-of-the-art production facility that adheres to Good Manufacturing Practice (GMP) standards. Its product portfolio encompasses various therapeutic classes, including antibiotics, analgesics, and treatments for chronic respiratory and cardiovascular conditions. Naba Al-Hayat aims to enhance the local healthcare infrastructure by providing affordable and accessible medication to the Iraqi population. The company plays a vital role in the domestic supply chain, working closely with national health authorities to meet the growing demand for essential drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NABA Alhyah Pharma.